CBD-Intel

World

This page includes all of our content relating to multiple countries around the world, including our full-length CBD market and regulatory reports, our extensive news coverage – both business and regulatory – our numerous trackers and databases, as well as our live alerts.

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions